In the last trading session, 38.82 million shares of the Ginkgo Bioworks Holdings Inc (NYSE:DNA) were traded, and its beta was 1.41. Most recently the company’s share price was $0.86, and it changed around -$0.06 or -6.46% from the last close, which brings the market valuation of the company to $1.76B. DNA currently trades at a discount to its 52-week high of $2.55, offering almost -196.51% off that amount. The share price’s 52-week low was $0.85, which indicates that the current value has risen by an impressive 1.16% since then. We note from Ginkgo Bioworks Holdings Inc’s average daily trading volume that its 3-month average coming to 23.06 million.

Ginkgo Bioworks Holdings Inc (NYSE:DNA) trade information

Instantly DNA has showed a red trend with a performance of -6.46% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -48.82% year-to-date, but still down -14.37% over the last five days. On the other hand, Ginkgo Bioworks Holdings Inc (NYSE:DNA) is -24.79% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $7.09, which translates to bulls needing to increase their stock price by 87.87% from its current value. Analyst projections state that DNA is forecast to be at a low of $4.35 and a high of $12.

Ginkgo Bioworks Holdings Inc (DNA) estimates and forecasts

Ginkgo Bioworks Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -47.58 percent over the past six months and at a 17.95% annual growth rate that is well above the industry average of 13.30%.

Ginkgo Bioworks Holdings Inc earnings are expected to increase by 30.43% in 2024, but the outlook is positive 19.50% per year for the next five years.

DNA Dividends

Ginkgo Bioworks Holdings Inc’s next quarterly earnings report is expected to be released in May.